A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Metabolic reprogramming is now recognized as a hallmark of cancer, playing a pivotal role in tumor progression, therapeutic resistance, immune evasion, and ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...

Chinese Pharmaceutical Companies Dominating Global Research & Development Landscape Of Bispecific ADC Market Says Kuick ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, today announced the launch of Sentinel ...

The Gross Law Firm issues the following notice to shareholders of Iovance Biotherapeutics, Inc. . Shareholders who purchased ...

Gene editing is a powerful technique which opens the possibility of genetic therapies which can rectify mutations which normally lead to disease. The use of ...

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 15, 2025 to file lead plaintiff applications in a ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

The FDA cleared an investigational new drug application for AVZO-1418/DB-1418, and a phase 1/2 trial in advanced solid tumors ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Mr. Altha Gene “Bo” Brantley, age 87, passed away Monday, May 26, 2025, at an Alabama hospital.